Korean J Obstet Gynecol.
2003 Sep;46(9):1790-1796.
A Case of Malignant Mixed Mullerian Tumor of Uterus after Tamoxifen Therapy for Breast Cancer
- Affiliations
-
- 1Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University, Seoul, Korea.
- 2Department of General Surgery, College of Medicine, Ewha Womans University, Seoul, Korea.
- 3Department of Pathology, College of Medicine, Ewha Womans University, Seoul, Korea.
Abstract
- Tamoxifen is widely used for the treatment of breast cancer and currently proposed for preventive strategies. However. there is evidence that tamoxifen may affect other hormone sensitive organs, such as uterus and ovary. It has been documented that tamoxifen treatment is associated with development of endometrial polyp, endometrial hyperplasia, ovarian and endometrial cancer. Uterine malignant mixed mullerian tumor is a neoplasm which apparently arises from undifferentiated mullerian stroma and is composed of a mixture of malignant epithelial and stromal component. We report a case of malignant mixed mullerian tumor of uterus which was developed in a patient treated with tamoxifen for 5 years following a modified radical mastectomy due to breast cancer.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Malignant Mixed Mullerian Tumor of the Uterus
- A Case of Malignant Mixed Mullerian Tumor of the Uterus with Neuroendocrine Differentiation
- A Case of Malignant Mixed Mullerian Tumor of Uterus Developed After Pelvic Irradiation
- Two Cases of Malignant Mixed Mullerian Tumor (MMMT) of the Ovary
- A Case of Malignant Mixed Mullerian Tumor of Uterus
